48 related articles for article (PubMed ID: 31933829)
1. The Prognostic and Immune Significance of BZW2 in Pan-Cancer and its Relationship with Proliferation and Apoptosis of Cervical Cancer.
Li C; Li Q; Li L; Sun S; Lei X
Front Biosci (Landmark Ed); 2024 Mar; 29(3):97. PubMed ID: 38538258
[TBL] [Abstract][Full Text] [Related]
2. Interactome Analysis Identifies the Role of BZW2 in Promoting Endoplasmic Reticulum-Mitochondria Contact and Mitochondrial Metabolism.
Maio G; Smith M; Bhawal R; Zhang S; Baskin JM; Li J; Lin H
Mol Cell Proteomics; 2024 Feb; 23(2):100709. PubMed ID: 38154691
[TBL] [Abstract][Full Text] [Related]
3. BZW2/5MP1 acts as a promising target in hepatocellular carcinoma.
Li G; Lu A; Chen A; Geng S; Xu Y; Chen X; Yang J
J Cancer; 2021; 12(17):5125-5135. PubMed ID: 34335929
[TBL] [Abstract][Full Text] [Related]
4. m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2.
Huang X; Yang Z; Li Y; Long X
Ann Hematol; 2023 Jul; 102(7):1801-1810. PubMed ID: 37222774
[TBL] [Abstract][Full Text] [Related]
5. Lung Cancer Gene Regulatory Network of Transcription Factors Related to the Hallmarks of Cancer.
Otálora-Otálora BA; López-Kleine L; Rojas A
Curr Issues Mol Biol; 2023 Jan; 45(1):434-464. PubMed ID: 36661515
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the role of Ly-1 antibody reactive in different cancer types.
Chen L; Jin C; Liu H; Feng R; Li Z; Zhang J
Bioengineered; 2021 Dec; 12(2):9452-9462. PubMed ID: 34696677
[TBL] [Abstract][Full Text] [Related]
7. PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple Myeloma.
Bai H; Zhu Y; Xu P; Chen B
Biomed Res Int; 2020; 2020():4286101. PubMed ID: 32596309
[TBL] [Abstract][Full Text] [Related]
8. Expression, oncological and immunological characterizations of BZW1/2 in pancreatic adenocarcinoma.
Ge J; Mu S; Xiao E; Tian G; Tao L; Li D
Front Genet; 2022; 13():1002673. PubMed ID: 36267402
[No Abstract] [Full Text] [Related]
9. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Liu X; Chen L; Zhang T
Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of BZW2 expression in lung adenocarcinoma patients.
Wang S; Bai W; Huang J; Lv F; Bai H
Int J Clin Exp Pathol; 2019; 12(12):4289-4296. PubMed ID: 31933829
[TBL] [Abstract][Full Text] [Related]
11. BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis.
Bucciarelli PR; Tan KS; Chudgar NP; Brandt W; Montecalvo J; Eguchi T; Liu Y; Aly R; Travis WD; Adusumilli PS; Jones DR
J Thorac Oncol; 2018 Jan; 13(1):73-84. PubMed ID: 29097253
[TBL] [Abstract][Full Text] [Related]
12. BZW2 promotes malignant progression in lung adenocarcinoma through enhancing the ubiquitination and degradation of GSK3β.
Jin K; Li Y; Wei R; Liu Y; Wang S; Tian H
Cell Death Discov; 2024 Feb; 10(1):105. PubMed ID: 38424042
[TBL] [Abstract][Full Text] [Related]
13. BZW2 Modulates Lung Adenocarcinoma Progression through Glycolysis-Mediated IDH3G Lactylation Modification.
Wang M; He T; Meng D; Lv W; Ye J; Cheng L; Hu J
J Proteome Res; 2023 Dec; 22(12):3854-3865. PubMed ID: 37955350
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
